Sansonno D E, Leandro G, Detomaso P, Papanice M A, Manghisi O G, Santantonio T, Pastore G
Hepatogastroenterology. 1985 Oct;32(5):226-8.
We considered the serum binding activity for human albumin polymerized with glutaraldehyde in 346 serum samples of 205 subjects with acute and chronic type A, B and non-A, non-B virus hepatitis. We showed that the binding activity for pHSA in the control groups did not have a titer higher than 2(-6). All sera from patients with HAV and HBV acute infection showed a high binding titer that returned to below the threshold in the former after the peak of hepatocytolysis, and in the latter after the seroconversion of HBsAg to anti-HBs. In the subjects who became HBsAg chronic carriers after the acute episode of HBV infection, the pHSA binding activity showed a decrement of the titer in relation to the seroconversion of HBeAg to anti-HBe. Furthermore, 92% of HBsAg chronic carriers who were HBeAg positive had a high titer of pHSA binding, while only 14.3% of the anti-HBe positives showed a high titer. Acute and chronic hepatitis non-A, non-B virus showed a pHSA binding titer similar to that of the control group. The results indicate that the non-A, non-B virus does not seem to be correlated to pHSA or related factors.
我们检测了205例急慢性甲型、乙型及非甲非乙型病毒肝炎患者的346份血清样本中与戊二醛聚合的人血清白蛋白的血清结合活性。结果显示,对照组中对聚合人血清白蛋白(pHSA)的结合活性效价不高于2(-6)。所有甲型肝炎病毒(HAV)和乙型肝炎病毒(HBV)急性感染患者的血清均显示出高结合效价,前者在肝细胞溶解高峰后效价恢复至阈值以下,后者在乙肝表面抗原(HBsAg)血清学转换为乙肝表面抗体(抗-HBs)后效价恢复至阈值以下。在HBV感染急性期后成为HBsAg慢性携带者的患者中,pHSA结合活性效价随HBeAg血清学转换为抗-HBe而降低。此外,92%的HBeAg阳性HBsAg慢性携带者具有高pHSA结合效价,而抗-HBe阳性者中只有14.3%显示高结合效价。急性和慢性非甲非乙型病毒肝炎的pHSA结合效价与对照组相似。结果表明,非甲非乙型病毒似乎与pHSA或相关因素无关。